Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
interleukin 2 receptor subunit gamma | 0.535 | 0.769 | 0.99 |
|
group | 0.800 | strong | 0.965 | 13 | 7 | 1989 | 2019 | ||||||||
|
KIT proto-oncogene, receptor tyrosine kinase | 0.366 | 0.808 | 0.98 |
|
group | 1.000 | definitive | 0.951 | 4 | 1 | 1995 | 2020 | ||||||||
|
ferredoxin 2 | 0.780 | 0.346 | 1.7E-03 |
|
group | 0.710 | strong | 1.000 | 2 | 2 | 2014 | 2018 | ||||||||
|
SET binding protein 1 | 0.503 | 0.808 | 1.00 |
|
group | 0.570 | None | 1.000 | 2 | 2 | 2013 | 2018 | ||||||||
|
platelet derived growth factor receptor alpha | 0.415 | 0.808 | 1.00 |
|
group | 0.800 | definitive | 0.954 | 2 | 0 | 2003 | 2020 | ||||||||
|
U2 small nuclear RNA auxiliary factor 1 | 0.604 | 0.577 | 0.99 |
|
group | 0.800 | None | 0.963 | 2 | 2 | 2011 | 2020 | ||||||||
|
collagen type IX alpha 2 chain | 0.572 | 0.769 | 1.0E-08 |
|
group | 0.550 | None | 1.000 | 1 | 1 | 1999 | 2016 | ||||||||
|
GATA binding protein 2 | 0.496 | 0.654 | 0.98 |
|
group | 0.800 | None | 0.976 | 1 | 1 | 2002 | 2019 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
group | 0.800 | None | 0.957 | 0 | 2 | 1994 | 2019 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
group | 0.800 | None | 1.000 | 0 | 0 | 1997 | 2019 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
group | 0.340 | None | 1.000 | 0 | 1 | 2001 | 2014 | ||||||||
|
CCCTC-binding factor | 0.504 | 0.769 | 1.00 |
|
group | 0.310 | None | 1.000 | 0 | 0 | 1998 | 1998 | ||||||||
|
CCCTC-binding factor | 0.504 | 0.769 | 1.00 |
|
group | 0.340 | None | 1.000 | 0 | 1 | 2003 | 2008 | ||||||||
|
defective in cullin neddylation 1 domain containing 3 | 0.87 |
|
group | 0.300 | None | 0 | 0 | |||||||||||||
|
APC regulator of WNT signaling pathway | 0.373 | 0.962 | 1.00 |
|
group | 0.900 | None | 0.982 | 0 | 2 | 1990 | 2019 | ||||||||
|
KIT proto-oncogene, receptor tyrosine kinase | 0.366 | 0.808 | 0.98 |
|
group | 0.300 | None | 0 | 1 | |||||||||||
|
menin 1 | 0.444 | 0.808 | 1.00 |
|
group | 0.400 | None | 0.971 | 0 | 2 | 1989 | 2017 | ||||||||
|
MRE11 homolog, double strand break repair nuclease | 0.527 | 0.808 | 1.3E-12 |
|
group | 0.400 | None | 0.964 | 0 | 3 | 2001 | 2019 | ||||||||
|
transforming growth factor beta receptor 2 | 0.413 | 0.846 | 0.13 |
|
group | 0.340 | None | 1.000 | 0 | 1 | 2001 | 2008 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
group | 0.700 | None | 0.947 | 0 | 5 | 1991 | 2019 | ||||||||
|
hydroxysteroid 17-beta dehydrogenase 10 | 0.656 | 0.538 | 0.94 |
|
phenotype | 0.750 | definitive | 1.000 | 12 | 8 | 1999 | 2019 | ||||||||
|
myosin heavy chain 9 | 0.505 | 0.808 | 1.00 |
|
phenotype | 1.000 | definitive | 1.000 | 11 | 13 | 1998 | 2020 | ||||||||
|
aspartylglucosaminidase | 0.570 | 0.808 | 4.3E-06 |
|
phenotype | 1.000 | None | 0.960 | 6 | 13 | 1990 | 2019 | ||||||||
|
LDL receptor related protein 5 | 0.485 | 0.846 | 0.51 |
|
phenotype | 0.600 | strong | 1.000 | 5 | 1 | 2001 | 2007 | ||||||||
|
caveolin 3 | 0.564 | 0.692 | 5.5E-03 |
|
phenotype | 0.700 | None | 1.000 | 5 | 3 | 2000 | 2005 |